The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Open accessAbstract
The genomes of various tumour cells contain mutant oncogenes that act dominantly, in that their effects can be observed when they are introduced into non-malignant cells. There is evidence for another class of oncogenes, in which tumour-predisposing mutations are recessive to wild-type alleles. Retinoblastoma is a prototype biological model for the study of such recessive oncogenes. This malignant tumour, which arises in the eyes of children, can be explained as the result of two distinct genetic changes, each causing loss of function of one of the two homologous copies at a single genetic locus, Rb, assigned to the q14 band of human chromosome 13. Mutations affecting this locus may be inherited from a parent, may arise during gametogenesis or may occur somatically. Those who inherit a mutant allele at this locus have a high incidence of non-ocular, second tumours, almost half of which are osteosarcomas believed to be caused by the same mutation. Here we describe the isolation of a complementary DNA segment that detects a chromosomal segment having the properties of the gene at this locus. The gene is expressed in many tumour types, but no RNA transcript has been found in retinoblastomas and osteosarcomas. The cDNA fragment detects a locus spanning at least 70 kilobases (kb) in human chromosome band 13q14, all or part of which is frequently deleted in retinoblastomas and osteosarcomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of RB also increases the risk of osteosarcoma development in children and teenagers18–20.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A simple and very efficient method for generating cDNA libraries
Gubler, U., & Hoffman, B. J. (1983) · Gene · doi:10.1016/0378-1119(83)90230-5 · Cited by 4,461
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., & White, R. L. (1983) · Nature · doi:10.1038/305779a0 · Cited by 1,919
Self-citationAutocrine growth factors and cancer
Sporn, M. B., & Roberts, A. B. (1985) · Nature · doi:10.1038/313745a0 · Cited by 1,425
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Cellular Oncogenes and Multistep Carcinogenesis
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Science · doi:10.1126/science.6356358 · Cited by 1,111
Self-citationGrowth factors: Mechanism of action and relation to oncogenes
Heldin, C., & Westermark, B. (1984) · Cell · doi:10.1016/0092-8674(84)90296-4 · Cited by 839
Evolution of tumours and the impact of molecular oncology
Klein, G., & Klein, E. (1985) · Nature · doi:10.1038/315190a0 · Cited by 655
Bishop, J. M. (1985) · Cell · doi:10.1016/s0092-8674(85)80098-2 · Cited by 617
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Knudson, A. G. Jr Cancer Res. 45, 1437–1443 (1985).
- Dryja, T. P. et al. Am. J. hum. Genet. 38, 59–66 (1986).
- Dryja, T. P. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
- McFall, R. C., Sery, T. W. & Makadon, M. Cancer Res. 37, 1003–1010 (1977).
Cited by
Sorted by citations
Items 301–400 of 999
Allelotype study of primary hepatocellular carcinoma.
Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., & Harada, H. (1991) · PubMed · Cited by 170
Patterns of risk of hereditary retinoblastoma and applications to genetic counselling
Draper, G., Sanders, B. M., Brownbill, P. A., & Hawkins, M. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.244 · Cited by 169
Neuroblastoma consensus deletion maps to 1p36.1–2
Weith, A., Martinsson, T., Cziepluch, C., Brüderlein, S., Amler, L. C., Berthold, F., & Schwab, M. (1989) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870010209 · Cited by 169
The search for the retinoblastoma cell of origin
Dyer, M. A., & Bremmer, R. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.05.013 · Cited by 169
Levine, A. J. (1990) · BioEssays · doi:10.1002/bies.950120203 · Cited by 168
Talmage, D. A., Freund, R., Young, A. T., Dahl, J., Dawe, C. J., & Benjamin, T. L. (1989) · Cell · doi:10.1016/0092-8674(89)90869-6 · Cited by 168
The retinoblastoma protein as a transcriptional repressor
Helin, K., & Harlow, E. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90150-y · Cited by 167
Diagnosis and Management of Retinoblastoma
Shields, C. L., & Shields, J. A. (2004) · Cancer Control · doi:10.1177/107327480401100506 · Cited by 166
Somatic alterations in the human cancer genome
Weir, B. A., Zhao, X., & Meyerson, M. M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.11.004 · Cited by 166
The retinoblastoma tumor-suppressor gene, the exception that proves the rule
Goodrich, D. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209616 · Cited by 170
“…DNA damage repair; apoptosis The retinoblastoma tumor-suppressor gene (Rb1) has been a focal point for research into the molecular underpinnings of cancer since its identification and cloning nearly 20 years ago (Dryja et al., 1986; Friend et al., 1986; Fung et al., 1987; Lee et al., 1987).”
BackgroundModelling mammalian cellular quiescence
Yao, G. (2014) · Interface Focus · doi:10.1098/rsfs.2013.0074 · Cited by 180
C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.
Shew, J., Lin, B. T., Chen, P., Tseng, B., Yang‐Feng, T. L., & Lee, W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.6 · Cited by 164
Beau, M. M. L., Epstein, N. D., O’Brien, S. J., Nienhuis, A. W., Yang, Y., Clark, S., & Rowley, J. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5913 · Cited by 164
Cairns, P., Tokino, K., Eby, Y. J., & Sidransky, D. (1994) · PubMed · Cited by 163
Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing.
Yandell, D. W., & Dryja, T. P. (1989) · PubMed · Cited by 163
Self-citationIto, Y., Matsuura∥, N., Sakon, M., Miyoshi, E., Noda, K., Takeda, T., Umeshita, K., Nagano, H., Nakamori, S., Dono, K., et al. (1999) · Hepatology · doi:10.1002/hep.510300114 · Cited by 162
Detection of mosaicRB1mutations in families with retinoblastoma
Rushlow, D., Piovesan, B., Zhang, K., Prigoda, N. L., Marchong, M. N., Clark, R. D., & Gallie, B. L. (2009) · Human Mutation · doi:10.1002/humu.20940 · Cited by 161
“1] at both loci [Dunn et al., 1988; Friend et al., 1986; Fung et al., 1987; Richter et al., 2003].”
Genetics and Molecular Diagnostics in Retinoblastoma — An Update
Soliman, S. E., Racher, H., Zhang, C., MacDonald, H. R., & Gallie, B. L. (2017) · Asia-Pacific Journal of Ophthalmology · doi:10.22608/apo.201711 · Cited by 165
Powers, S., O’Neill, K. E., & Wigler, M. H. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.2.390 · Cited by 161
The search for the retinoblastoma cell of origin
Dyer, M. A., & Bremner, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1545 · Cited by 170
“jpg" NDATA ITEM> ]> Since the first tumour-suppressor gene was identified in 1986 (Ref”
Knudson, A. G. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10320 · Cited by 160
Murakami, Y., Hayashi, K., & Sekiya, T. (1991) · PubMed · Cited by 161
Borghi, L., Gutzat, R., Fütterer, J., Laizet, Y., Hennig, L., & Gruissem, W. (2010) · The Plant Cell · doi:10.1105/tpc.110.074591 · Cited by 162
“Retinoblastoma (RB) was the first tumor suppressor gene identified in animals (Friend et al., 1986) and later was associatedwith cell cycle regulation, thus establishing pRb as a key regulator of cell proliferation.”
BackgroundMolecular characterization of the retinoblastoma susceptibility gene
Goodrich, D. W., & Lee, W. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90021-4 · Cited by 158
The spectrum of RB1 germ-line mutations in hereditary retinoblastoma.
Lohmann, D. R., Brandt, B., Höpping, W., Passarge, E., & Horsthemke, B. (1996) · PubMed Central · Cited by 157
Inactivation of p53 gene in human and murine osteosarcoma cells
Chandar, N., Billig, B., McMaster, J. H., & Novak, J. F. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.43 · Cited by 157
The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation
Martin, T. D., Patel, R. S., Cook, D. R., Choi, M. Y., Patil, A., Liang, A. C. T., Li, M. Z., Haigis, K. M., & Elledge, S. J. (2021) · Science · doi:10.1126/science.abg5784 · Cited by 154
The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.
Takahashi, R., Hashimoto, T., Xu, H., Hu, S., Matsui, T., Miki, T., Bigo-Marshall, H., Aaronson, S. A., & Benedict, W. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5257 · Cited by 156
Hensel, C. H. (1991) · Lung Cancer · doi:10.1016/0169-5002(91)90108-i · Cited by 156
Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli
Okamoto, M., Sasaki, M., Sugio, K., Sato, C., Iwama∥, T., Ikeuchi, T., Tonomura, A., Sasazuki, T., & Miyaki, M. (1988) · Nature · doi:10.1038/331273a0 · Cited by 156
Human cancer and cellular oncogenes
Nishimura, S., & Sekiya, T. (1987) · Biochemical Journal · doi:10.1042/bj2430313 · Cited by 153
MicroRNAs and Potential Targets in Osteosarcoma: Review
Sampson, V. B., Yoo, S., Kumar, A., Vetter, N. S., & Kolb, E. A. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00069 · Cited by 155
“Thus, loss of function of the RB1 gene drives tumorigenesis in many adult and pediatric cancers including OS (23, 24), retinoblastoma (25), medulloblastoma, supratentorial primitive neuroectodermal tumor (sPNET) (26), and acute lymphoblastic leukemia (ALL) (27).”
BackgroundMutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines
Andersen, L. B., Fountain, J. W., Gutmann, D. H., Tarlé, S. A., Glover, T. W., Dracopoli, N. C., Housman, D. E., & Collins, F. S. (1993) · Nature Genetics · doi:10.1038/ng0293-118 · Cited by 155
Constitutional RB1-Gene Mutations in Patients with Isolated Unilateral Retinoblastoma
Lohmann, D. R., Gerick, M., Brandt, B., Oelschläger, U., Lorenz, B., Passarge, E., & Horsthemke, B. (1997) · The American Journal of Human Genetics · doi:10.1086/514845 · Cited by 154
Kaye, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205834 · Cited by 153
Cell Proliferation of Estrogen-Sensitive Cells: The Case for Negative Control*
Soto, A. M., & Sonnenschein, C. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-44 · Cited by 153
Cell cycle in mouse development
Ciemerych, M. A., & Siciński, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208608 · Cited by 154
“Inactivation of Rb gene in humans leads to development of childhood eye tumors, retinoblastomas (Friend et al., 1986; Lee et al., 1987). pRb has also been shown to be responsible for the development of osteosarcomas, prostate and pituitary tumors, lymphomas and several other human malignancies…”
BackgroundPhillips, S. M. A., Barton, C., Lee, S. J., Morton, D. G., Wallace, D., Lemoine, N. R., & Neoptolemos, J. P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.482 · Cited by 152
Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma
Berry, J. L., Xu, L., Murphree, A. L., Krishnan, S., Stachelek, K., Zolfaghari, E. J., McGovern, K., Lee, T. C., Carlsson, A., Kühn, P., et al. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.4097 · Cited by 151
Allelotyping of human prostatic adenocarcinoma
Kunimi, K., Bergerheim, U. S. R., Larsson, I.-L., Ekman, P., & Collins, V. P. (1991) · Genomics · doi:10.1016/0888-7543(91)90059-n · Cited by 151
Pettenati, M. J., Beau, M. M. L., Lemons, R. S., Shima, E. A., Kawasaki, E. S., Larson, R. A., Sherr, C. J., Dı́az, M. O., & Rowley, J. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2970 · Cited by 151
Bone sarcomas as second malignant neoplasms following childhood cancer
Newton, W. A., Meadows, A. T., Shimada, H., Bunin, G. R., & Vawter, G. F. (1991) · Cancer · doi:10.1002/1097-0142(19910101)67:1 · Cited by 150
Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins
Felsani, A., Mileo, A. M., & Paggi, M. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209621 · Cited by 150
“…the RB gene was initially postulated on the basis of the incidence of retinoblastoma in children (Knudson, 1971), and in 1986, its cDNA was cloned (Friend et al., 1986) and, almost independently, other investigators recognized a set of cellular factors initially identified for their ability to…”
BackgroundGenetic Susceptibility of Benign Prostatic Hyperplasia
Sanda, M. G., Beaty, T. H., Stutzman, R. E., Childs, B., & Walsh, P. C. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32831-8 · Cited by 149
El-Azouzi, M., Chung, R. Y., Farmer, G. E., Martuza, R. L., Black, P. M., Rouleau, G. A., Hettlich, C., Hedley‐Whyte, E. T., Zervas, N. T., & Panagopoulos, K. P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7186 · Cited by 149
Mutations in the RB1 Gene and Their Effects on Transcription
Dunn, J. M., Phillips, R. A., Zhu, X., Becker, A., & Gallie, B. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.4596 · Cited by 150
Second primary tumors in patients with retinoblastoma a review of the literature
Moll, A. C., Imhof, S. M., Bouter, L. M., & Tan, K. E. W. P. (1997) · Ophthalmic Genetics · doi:10.3109/13816819709057880 · Cited by 147
Concerted Nonsyntenic Allelic Loss in Human Colorectal Carcinoma
Law, D., Olschwang, S., Monpezat, J.-P., Lefrançois, D., Jagelman, D. G., Petrelli, N. J., Thomas, G. D., & Feinberg, A. P. (1988) · Science · doi:10.1126/science.2841761 · Cited by 147
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF
Houdayer, C., Gauthier‐Villars, M., Laugé, A., Pagès-Berhouet, S., Dehainault, C., Caux‐Moncoutier, V., Karczynski, P., Tosi, M., Doz, F., Desjardins, L., et al. (2004) · Human Mutation · doi:10.1002/humu.10303 · Cited by 144
“2 [Friend et al., 1986].”
Genetic instability in cancer: Theory and experiment
BECKMAN, R., & Loeb, L. A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.007 · Cited by 145
“The retinoblastoma (Rb) gene was subsequently cloned [ 23 ] and shown to revert tumorigenic properties of cell lines deficient in its function [24].”
BackgroundA Mouse Model of the Aniridia-Wilms Tumor Deletion Syndrome
Glaser, T. M., Lane, J., & Housman, D. E. (1990) · Science · doi:10.1126/science.2173141 · Cited by 145
Sonoda, I., Imoto, I., Inoue, J., Shibata, T., Shimada, Y., Chin, K., Imamura, M., Amagasa, T., Gray, J. W., Hirohashi, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0172 · Cited by 144
Chen, J., Huang, X., Halicka, D., Brodsky, S., Avram, A., Eskander, J., Bloomgarden, N. A., Darzynkiewicz, Z., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00364.2005 · Cited by 142
Armstrong, C., Schubert, J. E. A., Ueda, E., Knez, J. J., Gelperin, D. M., Hirose, S., Silber, R., Hollán, S. R., Schmidt, R. E., & Medof, M. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74046-0 · Cited by 144
Genetics and Epigenetics of Human Retinoblastoma
Benavente, C. A., & Dyer, M. A. (2015) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040259 · Cited by 143
Identifying Tumor Suppressor Genes in Human Colorectal Cancer
Stanbridge, E. J. (1990) · Science · doi:10.1126/science.2403692 · Cited by 143
Furukawa, Y., DeCaprio, J. A., Freedman, A. S., Kanakura, Y., Nakamura, M., Ernst, T. J., Livingston, D. M., & Griffin, J. D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2770 · Cited by 139
Collateral lethality: a new therapeutic strategy in oncology
Muller, F. L., Aquilanti, E. A., & DePinho, R. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.002 · Cited by 132
“Di Fiore R, et al. RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis.”
BackgroundA detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma.
Yamakawa, K., Morita, R., Takahashi, E., Hori, T., Ishikawa, J., & Nakamura, Y. (1991) · PubMed · Cited by 142
Sidle, A., Palaty, C., Dirks, P., Wiggan, O., Kiess, M., Gill, R. M., Wong, A. K., & Hamel, P. A. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609106585 · Cited by 141
Constitutional translocation t(1;17)(p36;q12–21) in a patient with neuroblastoma
Laureys, G., Speleman, F., Opdenakker, G., Benoît, Y., & Leroy, J. (1990) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870020315 · Cited by 141
Chromosomal Abnormalities Subdivide Ependymal Tumors into Clinically Relevant Groups
Hirose, Y., Aldape, K., Bollen, A. W., James, C. D., Brat, D. J., Lamborn, K. R., Berger, M. S., & Feuerstein, B. G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64061-8 · Cited by 139
Kony, S., de Vathaire, F., Chompret, A., Shamsaldim, A., Grimaud, E., Raquin, M., Oberlin, O., Brugières, L., Feunteun, J., Eschwège, F., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01116-1 · Cited by 143
Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia
Pui, C., Williams, D., Raimondi, S. C., Rivera, G. K., Look, A. T., Dodge, R., George, S., Behm, F., Crist, W., & Murphy, S. (1987) · Blood · doi:10.1182/blood.v70.1.247.247 · Cited by 140
The Molecular Basis of Oncogenes and Tumor Suppressor Genes
Weinberg, R. A. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb24838.x · Cited by 140
Self-citationShimon, I., & Melmed, S. K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3987 · Cited by 140
Loss of Heterozygosity on Chromosome 19 in Secondary Glioblastomas
Nakamura, M., Yang, F., Fujisawa, H., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.6.539 · Cited by 139
Onadim, Z., Hogg, A., Baird, P. N., & Cowell, J. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6177 · Cited by 138
p53 abnormalities in different subtypes of human sarcomas.
Andreassen, Å. K., Øyjord, T., Hovig, E. J., Holm, R., Flørenes, V. A., Nesland, J. M., Myklebost, O., Høie, J., Bruland, Ø. S., & Børresen‐Dale, A. (1993) · PubMed · Cited by 138
Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130
Dannenberg, J.-H., Schuijff, L., Dekker, M., van der Valk, M., & Riele, H. T. (2004) · Genes & Development · doi:10.1101/gad.322004 · Cited by 137
“Inactivation of the retinoblastoma suppressor pRB has been found in many human cancers, including hereditary retinoblastoma and sporadic breast, bladder, prostate, and small cell lung carcinoma (Friend et al. 1986,”
BackgroundHuman Embryonic Stem Cell-Derived Organoid Retinoblastoma Reveals a Cancerous Origin
Liu, H., Zhang, Y., Zhang, Y.-Y., Li, Y.-P., Hua, Z.-Q., Zhang, C.-J., Jin, S., Zhang, C.-J., Wu, K.-C., Su, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011780117 · Cited by 137
“As a genetic malignancy, Rb is attributed mainly to biallelic inactivation of RB1 , a tumor-suppressor gene (2, 4, 22).”
Dai, H. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf085 · Cited by 137
Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer
DiCiommo, D. P., Gallie, B. L., & Bremner, R. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0326 · Cited by 138
Galindo, C. R., Orbach, D. B., & VanderVeen, D. K. (2014) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2014.09.014 · Cited by 148
Structure and partial genomic sequence of the human retinoblastoma susceptibility gene
McGee, T. L., Yandell, D. W., & Dryja, T. P. (1989) · Gene · doi:10.1016/0378-1119(89)90256-4 · Cited by 136
Self-citationGermline copy number variation and cancer risk
Kuiper, R. P., Ligtenberg, M. J. L., Hoogerbrugge, N., & van Kessel, A. G. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.005 · Cited by 141
Oncogenic potential of the DNA replication licensing protein CDT1
Arentson, E., Faloon, P. W., Seo, J., Moon, E., Studts, J., Fremont, D. H., & Choi, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205175 · Cited by 134
Role of the retinoblastoma gene in the initiation and progression of human cancer.
Benedict, W. F., Xu, H., Hu, S., & Takahashi, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114575 · Cited by 135
The Human Retinoblastoma Gene Is Imprinted
Kanber, D., Berulava, T., Ammerpohl, O., Mitter, D., Richter, J., Siebert, R., Horsthemke, B., Lohmann, D. R., & Buiting, K. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000790 · Cited by 134
“NM_000321) [7], encodes a nuclear phosphoprotein, pRb [8].”
BackgroundNon-ocular cancer in relatives of retinoblastoma patients
Sanders, B. M., Jay, M., Draper, G. J., & Roberts, E. P. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.285 · Cited by 134
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability
Ho, K. C., Zhou, Z., She, Y., Chun, A., Cyr, T. D., & Yang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101273108 · Cited by 134
Molecular pathogenesis of lung cancer
Fong, K. M., Sekido, Y., & Minna, J. D. (1999) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70121-2 · Cited by 132
Distal deletion of chromosome Ip in ductal carcinoma of the breast.
Genuardi, M., Tsihira, H., Anderson, D. E., & Saunders, G. F. (1989) · PubMed · Cited by 134
Ookawa, K., Sakamoto, M., Hirohashi, S., Yoshida, Y., Sügimura, T., Terada, M., & Yokota, J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530307 · Cited by 134
Miller, Y. E. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0158oe · Cited by 136
“Subsequently, cytogenetic and loss of heterozygosity (LOH) analysis confirmed Knudson’s hypothesis, and the Rb gene was cloned in 1986 (44, 45).”
BackgroundRb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb -deficient mice
de Bruin, A., Wu, L., Saavedra, H. I., Wilson, P. L., Yang, Y., Rosol, T. J., Weinstein, M. B., Robinson, M. L., & Leone, G. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031853100 · Cited by 132
Buard, A., Zipfel, P. A., Frey, R. S., & Mulder, K. M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960807)67:4 · Cited by 18
Deregulation of the Rb and p53 Pathways in Uveal Melanoma
Brantley, M. A., & Harbour, J. W. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64817-1 · Cited by 131
Hannan, K. M., Hannan, R. D., Smith, S. D., Jefferson, L. S., Lun, M., & Rothblum, L. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203875 · Cited by 131
Disease Diagnosis by Recombinant DNA Methods
Caskey, C. T. (1987) · Science · doi:10.1126/science.3296189 · Cited by 131
Nuclear protein phosphorylation and growth control
Meek, D. W., & Street, A. J. (1992) · Biochemical Journal · doi:10.1042/bj2870001 · Cited by 132
Tate, S. C., Cai, S., Ajamie, R. T., Burke, T., Beckmann, R. P., Chan, E. M., De Dios, A., Wishart, G. N., Gelbert, L. M., & Cronier, D. M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2846 · Cited by 130
“Since its discovery almost 30 years ago (1), the retinoblastoma protein (Rb) has received considerable attention for its role in cell-cycle controlwithin theRbpathway (2–4).”
BackgroundDevelopmental Genes and Cancer: Role of Patched in Basal Cell Carcinoma of the Skin
Gailani, M. R., & Bale, A. E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1103 · Cited by 130
13q deletions in lymphoid malignancies
Liu, Y., Hermanson, M., Grandér, D., Merup, M., Wu, X., Heyman, M. M., Rasool, O., Juliusson, G., Gahrton, G., & Detlofsson, R. (1995) · Blood · doi:10.1182/blood.v86.5.1911.bloodjournal8651911 · Cited by 130
Wang, K., Chen, Y., Ahn, S., Zheng, M., Landoni, E., Dotti, G., Savoldo, B., & Han, Z. (2020) · Nature Cancer · doi:10.1038/s43018-020-00119-y · Cited by 132
Pediatric tumors of the eye and orbit
Castillo, B. V., & Kaufman, L. M. (2003) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(02)00115-3 · Cited by 129
Dueck, M., Riedl, S., Hinz, U., Tandara, A. A., M�ller, P., Herfarth, C. H., & Faissner, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990812)82:4 · Cited by 57
Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas
Brooks, J. D., Bova, G. S., & Isaacs, W. B. (1995) · The Prostate · doi:10.1002/pros.2990260108 · Cited by 127
Cerón, J., Rual, J.-F. M., Chandra, A., Dupuy, D., Vidal, M., & van den Heuvel, S. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-30 · Cited by 126
“Background The retinoblastoma gene (Rb) was the first tumor suppressor gene to be genetically identified and cloned, based on germline mutations in familial cases of retinoblastoma [1].”
BackgroundRegulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
Metadata
- Authors
- Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P.
- Affiliations
- Harvard University (US)
- Whitehead Institute for Biomedical Research (US)
- Massachusetts Eye and Ear Infirmary (US)
- Venue
- Nature
- Published
- 1986-10
- Volume
- 323
- Issue
- 6089
- Pages
- 643-646
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2099742439
- Cited by
- 2,948
- References
- 43
- Citations by year
- 2026: 21 · 2025: 30 · 2024: 26 · 2023: 41 · 2022: 47 · 2021: 63 · 2020: 55 · 2019: 47 · 2018: 52 · 2017: 47 · 2016: 55 · 2015: 67 · 2014: 77 · 2013: 59 · 2012: 81
- FWCI
- 166.19
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- National Eye Institute (EY05321)
- National Cancer Institute (CA 39826)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- retinoblastoma, osteosarcoma, retinoblastoma gene, chromosome 13q14, cancer susceptibility, cDNA cloning, chromosomal deletion, second primary tumours, loss of heterozygosity
- MeSH terms
- Chromosome Deletion, Chromosome Mapping, Chromosomes, Human, Pair 13, Cloning, Molecular, DNA, DNA, Neoplasm, Genes, Recessive, Humans, Polymorphism, Restriction Fragment Length, Retina, Retinoblastoma, Osteosarcoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review